{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:42:01Z","timestamp":1765806121915,"version":"3.48.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.pcad.2025.11.001","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:11:22Z","timestamp":1762272682000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Multimodality imaging approaches for diagnosis of cardiac amyloidosis"],"prefix":"10.1016","volume":"93","author":[{"given":"Chaitanya","family":"Rojulpote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.M.","family":"Cuddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Foley","family":"Kijewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2025.11.001_bb0005","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0010","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J Cardiovasc Imagin"},{"key":"10.1016\/j.pcad.2025.11.001_bb0015","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","article-title":"Practical points for echocardiography in cardiac amyloidosis","volume":"35","author":"Cuddy","year":"2022","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2025.11.001_bb0020","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jtha.2024.05.018","article-title":"Thromboembolic and bleeding risk in cardiac amyloidosis","volume":"22","author":"Tana","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.pcad.2025.11.001_bb0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.echo.2024.02.005","article-title":"Myocardial texture analysis of echocardiograms in cardiac transthyretin amyloidosis","volume":"37","author":"Datar","year":"2024","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"10.1016\/j.pcad.2025.11.001_bb0030","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2025.11.001_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014645","article-title":"Optimal echocardiographic parameters to improve the diagnostic yield of Tc-99m-bone avid tracer cardiac scintigraphy for transthyretin cardiac amyloidosis","volume":"15","author":"Cuddy","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0040","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0045","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2025.11.001_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-verified regression of cardiac AL amyloid after chemotherapy","volume":"11","author":"Martinez-Naharro","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.3696","article-title":"Long-term efficacy of tafamidis in patients with transthyretin amyloid cardiomyopathy by National Amyloidosis Centre stage","author":"Damy","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2025.11.001_bb0065","article-title":"99mTechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis","author":"Dorbala","year":"2016","journal-title":"ASNC Practice Points"},{"key":"10.1016\/j.pcad.2025.11.001_bb0070","article-title":"99mTc bone-avid tracer cardiac scintigraphy: role in noninvasive diagnosis of transthyretin cardiac amyloidosis","volume":"306","author":"Khor","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.pcad.2025.11.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102078","article-title":"Current practices in amyloidosis imaging with bone-avid tracer cardiac scintigraphy","volume":"44","author":"Cuddy","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0080","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-diagnostic criteria and appropriate utilization","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.pcad.2025.11.001_bb0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/heartjnl-2022-321115","article-title":"Multimodality imaging of cardiac amyloidosis","volume":"110","author":"Benz","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2025.11.001_bb0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaccao.2021.08.009","article-title":"Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis outcomes survey","volume":"3","author":"Nativi-Nicolau","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0095","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pcad.2025.11.001_bb0100","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2025.11.001_bb0105","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0110","article-title":"Prognostic value of 99mtechnetium-PYP SPECT visual grade in patients with transthyretin cardiac amyloidosis on stabilization therapy","volume":"102275","author":"Pab\u00f3n","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0115","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2025.11.001_bb0120","series-title":"Expanding Indications for Non-biopsy Diagnosis of Transthyretin Amyloid Cardiomyopathy","first-page":"2199","volume":"Vol 44","author":"Dorbala","year":"2023"},{"key":"10.1016\/j.pcad.2025.11.001_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0130","first-page":"1419","article-title":"Cardiac amyloid quantification using 124I-evuzamitide (124I-P5+ 14) versus 18F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc OF","year":"2023","journal-title":"Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0135","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A routine PET\/CT protocol with streamlined calculations for assessing cardiac amyloidosis using 18F-florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0145","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","article-title":"Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds","volume":"45","author":"Wagner","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0150","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","article-title":"Early detection of multiorgan light-chain amyloidosis by whole-body 18F-florbetapir PET\/CT","volume":"60","author":"Ehman","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0155","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2967\/jnumed.121.263033","article-title":"Independent prognostic utility of 11C-Pittsburgh compound B PET in patients with light-chain cardiac amyloidosis","volume":"63","author":"Choi","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ehjci\/jeae332","article-title":"Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis","volume":"26","author":"Vergaro","year":"2025","journal-title":"Eur Heart J Cardiovasc Imagin"},{"key":"10.1016\/j.pcad.2025.11.001_bb0165","first-page":"911","article-title":"Prognostic value of left ventricular 18F-florbetapir uptake in systemic light-chain amyloidosis","volume":"17","author":"Clerc OF","year":"2024","journal-title":"Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2025.11.001_bb0170","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2025.11.001_bb0175","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic accuracy of [(11)C]PIB positron emission tomography for detection of cardiac amyloidosis","volume":"13","author":"Rosengren","year":"2020","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2025.11.001_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2025.07.017","article-title":"Changes in myocardial light chain amyloid burden after plasma cell therapy","author":"Benz","year":"2025","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2025.11.001_bb0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0190","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0200","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jcmg.2024.11.003","article-title":"Development of imaging endpoints for clinical trials in AL and ATTR amyloidosis: proceedings of the amyloidosis forum","volume":"18","author":"Dorbala","year":"2025","journal-title":"J Am Coll Cardiol Img"},{"issue":"6","key":"10.1016\/j.pcad.2025.11.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009038","article-title":"Proposed cardiac end points for clinical trials in immunoglobulin light chain amyloidosis: report from the amyloidosis forum cardiac working group","volume":"15","author":"Maurer","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2025.11.001_bb0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/eurheartj\/ehab507","article-title":"Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis","volume":"43","author":"Cohen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.11.001_bb0215","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imagin"},{"key":"10.1016\/j.pcad.2025.11.001_bb0220","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamacardio.2024.2555","article-title":"Redefining cardiac involvement and targets of treatment in systemic immunoglobulin AL amyloidosis","volume":"9","author":"Porcari","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.pcad.2025.11.001_bb0225","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jcmg.2024.05.004","article-title":"Myocardial characteristics, cardiac structure, and cardiac function in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2025.11.001_bb0235","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejhf.2198","article-title":"Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2025.11.001_bb0240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaccao.2021.08.007","article-title":"Effect of Tafamidis on serum transthyretin levels in non-trial patients with transthyretin amyloid cardiomyopathy","volume":"3","author":"Falk","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102019","article-title":"Quantitative (99m)Tc-pyrophosphate myocardial uptake: changes on transthyretin stabilization therapy","volume":"39","author":"Vijayakumar","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0250","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","article-title":"Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis","volume":"23","author":"Casta\u00f1o","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0255","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid","volume":"389","author":"Garcia-Pavia","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0260","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2025.06.009","article-title":"Regression of myocardial bone-avid tracer uptake after ATTR-CM disease-modifying therapy: is this a new post-treatment phenotype?","volume":"18","author":"Dorbala","year":"2025","journal-title":"J Am Coll Cardiol Img"},{"issue":"2","key":"10.1016\/j.pcad.2025.11.001_bb0265","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcmg.2023.10.010","article-title":"Current and evolving multimodality cardiac imaging in managing transthyretin amyloid cardiomyopathy","volume":"17","author":"Alwan","year":"2024","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.pcad.2025.11.001_bb0270","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/echo.15516","article-title":"Artificial intelligence based left ventricular ejection fraction and global longitudinal strain in cardiac amyloidosis","volume":"40","author":"Cotella","year":"2023","journal-title":"Echocardiography"},{"issue":"40","key":"10.1016\/j.pcad.2025.11.001_bb0275","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1093\/eurheartj\/ehaf387","article-title":"Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool","volume":"46","author":"Slivnick","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2025.11.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101809","article-title":"Deep learning approach for automated segmentation of myocardium using bone scintigraphy single-photon emission computed tomography\/computed tomography in patients with suspected cardiac amyloidosis","volume":"33","author":"Bhattaru","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.pcad.2025.11.001_bb0285","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2967\/jnumed.124.267542","article-title":"Deep learning\u2013enabled quantification of 99mTc-Pyrophosphate SPECT\/CT for cardiac amyloidosis","volume":"65","author":"Miller","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pcad.2025.11.001_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035599","article-title":"Deep learning virtual contrast-enhanced T1 mapping for contrast-free myocardial extracellular volume assessment","volume":"13","author":"Nowak","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2025.11.001_bb0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12968-020-00690-4","article-title":"Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance","volume":"22","author":"Martini","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.pcad.2025.11.001_bb0300","article-title":"Enhanced diagnostic and prognostic assessment of cardiac amyloidosis using combined 11C-PiB PET\/CT and 99mTc-DPD scintigraphy","volume":"1-12","author":"Hong","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062025001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T05:08:09Z","timestamp":1765775289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062025001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":59,"alternative-id":["S0033062025001641"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2025.11.001","relation":{},"ISSN":["0033-0620"],"issn-type":[{"type":"print","value":"0033-0620"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality imaging approaches for diagnosis of cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}